Topics

Malignant Glioma Pipeline Review2019 [Published by First View Insight] Prices from USD $1063

05:50 EST 2 Feb 2020 | BioPortfolio Reports

Firstview Insight's Malignant Glioma Pipeline Review2019 provides an overview of the pipeline landscape of Malignant Glioma It provides comprehensive insights of all the clinical and nonclinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the upcoming and existing competitors in their separate therapeutic spaces. The report provides detailed description of the competitor profiles with key milestones and evidence along with analysis by mechanism of action; route of administration; molecule type; stage of development. Information obtained from multiple sources will be used to triangulate and update the profiles. The report also provides key events in the last year related to the indication. This report provides detailed analysis of all the products along with the companies involved.

Glioma is a type of tumor that occurs in the brain and spinal cord. Gliomas begin in the gluey supportive cells glial cells that surround nerve cells and help them function.

Three types of glial cells can produce tumors. Gliomas are classified according to the type of glial cell involved in the tumor, as well as the tumor's genetic features, which can help predict how the tumor will behave over time and the treatments most likely to work.

Types of glioma include:

Astrocytomas, including astrocytoma, anaplastic astrocytoma and glioblastoma

Ependymomas, including anaplastic ependymoma, myxopapillary ependymoma and subependymoma

Oligodendrogliomas, including oligodendroglioma, anaplastic oligodendroglioma and anaplastic oligoastrocytoma

A glioma can affect brain function and be lifethreatening depending on its location and rate of growth.

Gliomas are one of the most common types of primary brain tumors.

The type of glioma you have helps determine your treatment and your prognosis. In general, glioma treatment options include surgery, radiation therapy, chemotherapy, targeted therapy and experimental clinical trials.


Types

Astrocytoma

Ependymoma

Glioblastoma

Oligodendroglioma

Symptoms

The symptoms of glioma vary by tumor type as well as the tumor's size, location and rate of growth.

Drug Profile Overview:

The pipeline section provides descriptive drug profiles for the pipeline products including product description, mechanism of action, route of administration, molecule type, technology involved, chemical information.


Clinical Trial Overview:

This section of the report focuses on the clinical activity of the molecule. It includes both clinical and preclinical activity which provides detailed information about the safety, efficacy, tolerability, toxicity of pipeline drugs. A graphical representation of the clinical trial landscape of pipeline therapy which includes information about phase of development, trial design, treatment arms, dosage and frequency, formulation of the drug, primary and secondary completion date, enrolment number, exclusion and inclusion criteria, line of therapy. This section also includes the clinical trial results and analysis based on those results.


Product Development Activity:

This section of the report focuses on detail information about designations, exclusivity details, technology, licensing and collaboration, funding and financing, key milestones and various other development activities.


Company Overview:

Company profile includes the detail about type of company, headquarter, global presence, research focus and key financial


Scope

The report provides a competitive landscape

The report also provides clinical trial landscape of the pipeline drugs including status; trial phase; sponsor type and endpoint status

The report provides the list of companies which are the most active in the pipeline

The report covers pipeline products based on various stages of development ranging from preregistration till discovery

The report provides descriptive drug profiles which includes product description; comprising detailed mechanism of action MoA; route of administration RoA; Stage of development; clinical trial status; licensing and collaboration details other developmental activities

The report features comparative analysis of product profiles based on molecule type; mechanism of action MoA; route of administration RoA

The report summarizes all the dormant and discontinued pipeline projects

The report also provides latest news for the past one year


Reasons To Buy

To identifying prominent players in the treatment landscape

To determine the drivers; barriers and unmet need in the treatment space

Gain strategically significant competitor information; analysis; and insights to formulate effective RD strategies

Define inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

To understand the composition of the pipeline in terms of molecule type; molecular target; mechanism of action and route of administration


List of products

Afinitor Everolimus

Afinitor Disperz Everolimus

Avastin Bevacizumab

Bevacizumab.

BiCNU Carmustine

Carmustine.

Carmustine Implant.

Everolimus.

Original Article: Malignant Glioma Pipeline Review2019 [Published by First View Insight] Prices from USD $1063

NEXT ARTICLE

More From BioPortfolio on "Malignant Glioma Pipeline Review2019 [Published by First View Insight] Prices from USD $1063"

Quick Search

Relevant Topics

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...

Brain Cancer
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...